Business Wire

Boosting Cardiovascular Health in Europe – Towards More Resilient and Equitable Healthcare


More than two years after the COVID-19 pandemic started, healthcare systems are taking stock of the lessons learnt to strengthen their response and improve the health outcomes of patients across disease areas. In this context, theEuropean Federation of Pharmaceutical Industries and Associations (EFPIA)CVD Network commissioned a report in collaboration with PwC on “Boosting cardiovascular health in Europe: towards more resilient and equitable healthcare”, to assess the impact of COVID-19 on cardiovascular (CVD) care and to explore possible policy actions to strengthen the healthcare systems’ response to CVDs.

The report finds that:

  • Cardiovascular disease (CVD) is the major cause of mortality and morbidity across Europe, affecting almost 95 million patients and, notably causing 1.24 million acute coronary events each year.
  • CVD accounts for almost one-third of all premature deaths and is responsible for 23 % of all disability-adjusted life years (DALYs) measured across Europe, exceeding the burden caused by all other non-communicable diseases (NCDs), including cancer.
  • At the same time, many CVDs are preventable or, at least, manageable with appropriate interventions, often more so than other major NCDs. Overall, about 70% of the CVD burden is attributable to risk factors that can be controlled or modified, such as hypertension, high cholesterol or diabetes.
  • COVID-19 has made things worse. The pandemic has increased the risk of hospitalisation and death for people with CVD and put healthcare systems under strain, disrupting detection and care pathways and exposing existing disparities in CVD care.
  • Short-term shocks, similar to the pandemic, are likely to become more frequent, thus boosting healthcare demand, and stretching healthcare services even further.
  • Evolving disease patterns will force healthcare systems to reshape their care delivery models. With 130 million Europeans expected to be over the age of 65 by 2050, CVD-related healthcare demand is bound to grow and transform over the coming decades.

Following the findings, the report offers a series of concrete policy recommendations that aim to re-design CVD care and equip European healthcare systems with the necessary tools to cope with future crises:

  • Strengthen population screening
    • Broaden screening programmes for genetic and metabolic risk factors
    • Simplify access to screening, especially for vulnerable populations
  • Ensure treatment initiation, maintenance, and follow-up for at-risk patients
    • Re-design healthcare systems to reward outcomes
    • Strengthen digital health and information sharing to improve disease management
  • Foster data-driven decision making
    • Harness the potential of data-driven solutions to inform CVD policies and support clinical decision-making and value-based care delivery

Cardiovascular diseases are Europe’s biggest health challenge. The time to act is now. Building on the available evidence, we need bold policy action for better population health in Europe” commented Christian Thonke and Sean Lybrand, co-Chairs of the EFPIA CVD Network.

The Report calls on all CVD stakeholders to play their part in advancing CVD prevention, detection and care, by putting the spotlight on secondary prevention and encouraging a smarter use of digital technologies.

To view this piece of content from, please give your consent at the top of this page.

Contact information

Andy Powrie-Smith, Executive Director of Communications, EFPIA

About Business Wire

Business Wire
Business Wire

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lunaphore Expands Its COMET™ Portfolio to Become the First Universal, End-to-end Spatial Biology Solution28.3.2023 17:00:00 CEST | Press release

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced the launch of a full expansion of its product offering to provide a universal, end-to-end spatial biology solution, answering the needs of the scientific community from early discovery to late-stage translational and clinical research. This milestone marks the launch of the enhanced version of the company’s revolutionary COMET™ platform and its comprehensive product suite, which includes a wide range of tools and applications across all research and drug development stages. This press release features multimedia. View the full release here: Lunaphore's universal, end-to-end spatial biology solution portfolio. (Photo: Lunaphore) Lunaphore’s multiplex immunofluorescence (mIF) solution portfolio now includes the latest version of the hyperplex, high-throughput, fully automated COMET™ instrument, providing un

Yokohama Business Events Website Redesign: Discover Yokohama in the Here and Now With Technical-Visits* and New Videos!28.3.2023 17:00:00 CEST | Press release

The Yokohama Convention & Visitors Bureau (YCVB) website is an important point of contact for convention organizers and incentive-travel planners in Japan and around the world. Today, we are announcing that our website has been completely redesigned and now offers new and exclusive experiences for business events—experiences that can be had only in the city of Yokohama. On our new website, organizers can find convenient ways to add value to their conferences and attract more participants as people return to in-person events. Yokohama is a global leader in international conferences with numerous event facilities, excellent accommodations, and tourist attractions conveniently located within the Yokohama bay area. Given the growing demand for close interaction with local communities and the many different types of business events, we have created a new web page featuring technical-visit programs and have given sustainability a larger place in our content. Additionally, compelling videos o

Exclusively for Business Event Participants: Sustainable experiences available only in Yokohama28.3.2023 17:00:00 CEST | Press release

Now, more than ever, a sustainable approach is essential for successful international conferences and events. At Yokohama Convention & Visitors Bureau (YCVB), we value sustainability in all our activities and do our utmost to contribute to a greener, more inclusive, and culturally diverse world. We have therefore created four amazing sustainable experiences, which are exclusively for business event participants, and unique to the city of Yokohama. Yokohama Mobile Yoga Experience yoga anytime and anywhere in the vibrant metropolis of Yokohama. This wellness activity can be held anywhere—parks, conference rooms, or exhibition halls. Inspired by Yokohama’s natural beauty, the yoga sessions use the calming sound of waves, delicate aromas, and images of Yokohama’s beautiful sea to create a relaxing and meditative experience for business event participants. To ensure accessibility to all, the sessions can be arranged for any level of experience, can be held in Japanese and English, and don’t

ReNew Repays More Than $1 Billion to Offshore Bondholders in FY202328.3.2023 16:02:00 CEST | Press release

ReNew Energy Global Plc (“ReNew” or “the Company”) (Nasdaq: RNW, RNWWW), India’s leading clean energy company and a preferred decarbonisation partner, announced on Tuesday that it has repaid more than $1 billion to its offshore bondholders in FY 2023. The amount repaid includes the most recent amortisation of $180 million this month. “In today’s fast-paced global business environment, firms must be very strategic in financing for the growth initiatives,” said Kedar Upadhye, CFO of ReNew. “As ReNew and India lead the global energy transition, we have continued to mitigate refinancing risk without diminishing the company’s growth capital.” Over the past fiscal year, the Nasdaq-listed company refinanced $525 million in the domestic markets ahead of the March 2024 maturity, in addition to repayment of $300 Million from its internal cash flow accruals. Post this refinancing, asset-backed bonds worth $325 million would be due for repayment in FY2025, while the rest of the dollar bonds worth

Monstarlab Holdings Inc. Becomes Independent Publicly Traded Company, Begins Trading on Tokyo Stock Exchange28.3.2023 16:01:00 CEST | Press release

Monstarlab Holdings Inc. (TYO: 5255), a global digital transformation consultancy leader, specializing in end-to-end enterprise-level digital solutions, celebrated its debut as a public company today. CEO, Hiroki Inagawa, joined senior leadership, company employees and investors to ring the Opening Bell at the Tokyo Stock Exchange Growth Market. This announcement provides the springboard for further growth and enhances Monstarlab’s presence in the United States, Canada and Colombia. This press release features multimedia. View the full release here: CEO Hiroki Inagawa with the Monstarlab senior leadership team at the Tokyo Stock Exchange. (Photo: Business Wire) Monstarlab, founded in 2006, brings its specialized approach of human-centered design coupled with digital strategy and optimization to a broad set of clients all over the world. The company has a long history of delivering results for leaders across a myriad of industrie

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom